NutriBand (NTRB) Other Non-Current Liabilities (2019 - 2024)

NutriBand (NTRB) posted Other Non-Current Liabilities of $300000.0 for Q2 2024, down 85.0% sequentially from $2.0 million in Q4 2023.

NutriBand (NTRB) Other Non-Current Liabilities (2019 - 2024) Analysis & Trends

NutriBand has reported Other Non-Current Liabilities for 4 years, with the latest figure at $300000.0 in Q2 2024.

Quarterly Other Non-Current Liabilities changed N/A year-over-year to $300000.0 in Q2 2024, while the trailing twelve-month figure through Apr 2024 was $300000.0 (changed N/A YoY) and the FY2020 annual result came in at $928774.0, changed N/A from the prior year.
Other Non-Current Liabilities declined to $300000.0 in Q2 2024 per NTRB's latest filing, from $2.0 million in the prior quarter.
Over five years, Other Non-Current Liabilities peaked at $2.0 million in Q4 2023 and troughed at $300000.0 in Q2 2024.
A 3-year average of $1.1 million and a median of $928774.0 in 2020 frame the typical range for Other Non-Current Liabilities.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	NutriBand	57.74 Mn	53.73 Mn	196,801.00

Download Data